On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Addgene

InstitutionResearch output, impact & collaborations

Addgene is a institution indexed in ScholarIQ from OpenAlex.

What is known about Addgene?

ScholarIQrecord summary

Addgene is a research organisation in Cambridge, US. OpenAlex records 483 works and 56,342 citations for it. 356 researchers list it as their most recent affiliation.

How many works does Addgene have?

ScholarIQindexed works

Addgene has 483 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Addgene have?

ScholarIQcitation count

Addgene has 56,342 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Addgene?

ScholarIQresearcher count

Addgene has 356 researchers in the ScholarIQ index.

What is the average h-index at Addgene?

ScholarIQavg h-index

Addgene has an average h-index of 74 in OpenAlex.

What is the ROR of Addgene?

ScholarIQror

The ROR for Addgene is on the source record.

What is the OpenAlex record for Addgene?

ScholarIQopenalex

The OpenAlex for Addgene is on the source record.

Who are the most-cited researchers behind Addgene?

ScholarIQtop researchers by citations
1
Jochen K. Lennerz · Lung Cancer Treatments and Mutations
629 works22,916 citations

What are the most-cited papers on Addgene?

ScholarIQmost cited works
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
Ken Cadwell, John Y. Liu, Sarah L. Brown, Hiroyuki Miyoshi, Joy Loh, Jochen K. Lennerz, Chieko Kishi, Wumesh KC, Javier A. Carrero, Steven R. Hunt, Christian D. Stone, Elizabeth M. Brunt, Ramnik J. Xavier, Barry P. Sleckman, Ellen Li, Noboru Mizushima, Thaddeus S. Stappenbeck, Herbert W. Virgin
Nature. 20081,507 CitationsOPEN ACCESS
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Marina Cella, Anja Fuchs, William Vermi, Fabio Facchetti, Karel Otero, Jochen K. Lennerz, Jason M. Doherty, Jason C. Mills, Marco Colonna
Nature. 20081,223 CitationsOPEN ACCESS
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer
Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo‐Jack, Shirish M. Gadgeel, Katherine R. Schultz, Manrose Singh, Emily Chin, Melissa Parks, Dana Lee, Richard H. DiCecca, Elizabeth L. Lockerman, Tiffany G. Huynh, Jennifer Logan, Lauren L. Ritterhouse, Long P. Le, Ashok Muniappan, Subba R. Digumarthy, Colleen L. Channick, Colleen Keyes, Gad Getz, Dora Dias‐Santagata, Rebecca S. Heist, Jochen K. Lennerz, Lecia V. Sequist, Cyril H. Benes, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman, Alice T. Shaw
Cancer Discovery. 20161,157 CitationsOPEN ACCESS
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, Diane Yang, Tyler E. Miller, Jared Feldman, Blake M. Hauser, Timothy M. Caradonna, Kiera Clayton, Adam D. Nitido, Mandakolathur R. Murali, Galit Alter, Richelle C. Charles, Anand S. Dighe, John A. Branda, Jochen K. Lennerz, Daniel Lingwood, Aaron G. Schmidt, A. John Iafrate, Alejandro B. Balazs
Cell. 2020793 CitationsOPEN ACCESS
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
Lipika Goyal, Supriya K. Saha, Leah Y. Liu, Giulia Siravegna, Ignaty Leshchiner, Leanne G. Ahronian, Jochen K. Lennerz, Phuong Vu, Vikram Deshpande, Avinash Kambadakone, Benedetta Mussolin, Stephanie Reyes, Laura E. Henderson, Jiaoyuan Elisabeth Sun, Emily E. Van Seventer, Joseph M. Gurski, Sabrina Baltschukat, Barbara Schacher-Engstler, Louise Barys, Christelle Stamm, Pascal Furet, David P. Ryan, James R. Stone, A. John Iafrate, Gad Getz, Diana Graus Porta, Ralph Tiedt, Alberto Bardelli, Dejan Juric, Ryan B. Corcoran, Nabeel Bardeesy, Andrew X. Zhu
Cancer Discovery. 2016550 CitationsOPEN ACCESS

How much of the research on Addgene is open access?

ScholarIQopen access share
83%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
8%
Bronze
25%
Closed
17%

Related on ScholarIQ

470M+ articles · 14-day free trial